Months after charging two Indian companies of “criminal conspiracies” to smuggle fentanyl precursors into the United States, the U.S. Embassy on Thursday (September 18, 2025) said that it has revoked and denied visas for “certain” Indian “business executives and corporate leadership”, accusing them of smuggling ingredients that are used in the illegal production of the drug.
In a statement, the U.S. Embassy said that the “family members” of these business executives would also “face consequences” for the illegal production and trafficking of drugs to the United States.
